BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11078417)

  • 1. Endothelin-receptor antagonists in uremic cardiomyopathy.
    Wolf SC; Gaschler F; Brehm S; Klaussner M; Amann K; Risler T; Brehm BR
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S348-50. PubMed ID: 11078417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of endothelin receptor antagonists on myocardial protein kinase C isoforms in uraemic cardiomyopathy.
    Wolf SC; Amend T; Risler T; Amann K; Brehm BR
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():276S-279S. PubMed ID: 12193103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of endothelin antagonists in chronic renal failure.
    Wolf SC; Brehm BR; Gaschler F; Brehm S; Klaussner M; Smykowski J; Amann K; Osswald H; Erley CM; Risler T
    Nephrol Dial Transplant; 1999; 14 Suppl 4():29-30. PubMed ID: 10463205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of endothelin receptor antagonism on smooth muscle cell proliferation after chronic renal failure.
    Sauter G; Wolf S; Risler T; Brehm B
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S165-7. PubMed ID: 15838271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin receptor antagonists influence cardiovascular morphology in uremic rats.
    Nabokov AV; Amann K; Wessels S; Münter K; Wagner J; Ritz E
    Kidney Int; 1999 Feb; 55(2):512-9. PubMed ID: 9987075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remodeling of resistance arteries in renal failure: effect of endothelin receptor blockade.
    Amann K; Mil Tenberger-Mil Tenyi G; Simonoviciene A; Koch A; Orth S; Ritz E
    J Am Soc Nephrol; 2001 Oct; 12(10):2040-2050. PubMed ID: 11562402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin ET(A) receptor blockade prevents the progression of renal failure and hypertension in uraemic rats.
    Brochu E; Lacasse S; Moreau C; Lebel M; Kingma I; Grose JH; Larivière R
    Nephrol Dial Transplant; 1999 Aug; 14(8):1881-8. PubMed ID: 10462266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with a combined endothelin A/B-receptor antagonist does not prevent chronic renal allograft rejection in rats.
    Braun C; Conzelmann T; Vetter S; Schaub M; Back WE; Kirchengast M; Tullius SG; Schnülle P; van der Woude FJ; Rohmeiss P
    J Cardiovasc Pharmacol; 2000 Oct; 36(4):428-37. PubMed ID: 11026642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of growth factors on the proliferation of vascular smooth muscle cells isolated from subtotally nephrectomized rats after endothelin or angiotensin II antagonism.
    Wolf SC; Sauter G; Rodemann HP; Risler T; Brehm BR
    Nephrol Dial Transplant; 2005 Feb; 20(2):312-8. PubMed ID: 15585510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of endothelin-1 antagonists on erythropoietin-induced hypertension in renal failure.
    Brochu E; Lacasse S; Larivière R; Kingma I; Grose JH; Lebel M
    J Am Soc Nephrol; 1999 Jul; 10(7):1440-6. PubMed ID: 10405199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin A receptor blockade prevents capillary/myocyte mismatch in the heart of uremic animals.
    Amann K; Münter K; Wessels S; Wagner J; Balajew V; Hergenröder S; Mall G; Ritz E
    J Am Soc Nephrol; 2000 Sep; 11(9):1702-1711. PubMed ID: 10966495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats.
    Amann K; Gassmann P; Buzello M; Orth SR; Törnig J; Gross ML; Magener A; Mall G; Ritz E
    Kidney Int; 2000 Jul; 58(1):153-61. PubMed ID: 10886560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function.
    Yamauchi-Kohno R; Miyauchi T; Hoshino T; Kobayashi T; Aihara H; Sakai S; Yabana H; Goto K; Sugishita Y; Murata S
    Circulation; 1999 Apr; 99(16):2171-6. PubMed ID: 10217659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic exposure to carbon monoxide and nicotine: endothelin ET(A) receptor antagonism attenuates carbon monoxide-induced myocardial hypertrophy in rat.
    Loennechen JP; Nilsen OG; Arbo I; Aadahl P; Nilsen T; Waldum HL; Sandvik AK; Ellingsen O
    Toxicol Appl Pharmacol; 2002 Jan; 178(1):8-14. PubMed ID: 11781074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of combined endothelin and angiotensin II antagonism on growth factor-induced proliferation of vascular smooth muscle cells isolated from uremic rats.
    Wolf SC; Sauter G; Risler T; Brehm BR
    Ren Fail; 2005; 27(4):465-74. PubMed ID: 16060137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure.
    Francis B; Winaver J; Karram T; Hoffman A; Abassi Z
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S54-8. PubMed ID: 15838359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different roles of two types of endothelin receptors in partial ablation-induced chronic renal failure in rats.
    Shimizu T; Hata S; Kuroda T; Mihara S; Fujimoto M
    Eur J Pharmacol; 1999 Sep; 381(1):39-49. PubMed ID: 10528132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
    Mulder P; Richard V; Derumeaux G; Hogie M; Henry JP; Lallemand F; Compagnon P; Macé B; Comoy E; Letac B; Thuillez C
    Circulation; 1997 Sep; 96(6):1976-82. PubMed ID: 9323089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation.
    Nabokov A; Amann K; Wagner J; Gehlen F; Münter K; Ritz E
    Nephrol Dial Transplant; 1996 Mar; 11(3):514-20. PubMed ID: 8671823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin receptor A blockade reduces proteinuria and vascular hypertrophy in spontaneously hypertensive rats on high-salt diet in a blood-pressure-independent manner.
    Trenkner J; Priem F; Bauer C; Neumayer HH; Raschak M; Hocher B
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():385S-388S. PubMed ID: 12193128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.